3rd Quarter - Amendment

COUNCIL FOR RESPONSIBLE NUTRITION for COUNCIL FOR RESPONSIBLE NUTRITION

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 21, 2019 $100,000 Replaced
3rd Quarter - Amendment (this page) Sep 28, 2020 $100,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Increased funding for the Office of Dietary Supplement Programs (ODSP) within FDA.

LobbyistCovered position, as disclosed
MIKE GREENE —
STEVEN MISTER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Defense DEF

Dietary Supplement-related AER Amendment Offered to Defense Authorization. Would require the Defense Department to document and communicate information of adverse event report data regarding dietary supplement use to FDA.

LobbyistCovered position, as disclosed
MIKE GREENE —
STEVEN MISTER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Agriculture AGR

HR 3142, S 1717 - SNAP Vitamin & Mineral Improvement Act introduced by Sens. Tim Scott (R-SC), Kyrsten Sinema (D-AZ) and Reps. Tony Cardenas (D-CA), Mike Rogers (R-AL), which would provide low-income Americans to purchase a multivitamin-mineral with their SNAP benefits.

LobbyistCovered position, as disclosed
MIKE GREENE —
STEVEN MISTER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3142 (116th)

Taxation/Internal Revenue Code TAX

S. 12-Health Savings Act of 2019, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions relating to dietary supplements

LobbyistCovered position, as disclosed
MIKE GREENE —
STEVEN MISTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 12 (116th)

Consumer Issues/Safety/Products CSP

Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. Policy initiatives on Selective Androgen Receptor Modulators (SARMs)

LobbyistCovered position, as disclosed
MIKE GREENE —
STEVEN MISTER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.